Vital Chemtech Reports Strong H1 FY27 Results and Board Reshuffle
Vital Chemtech Ltd · Outcome · 02 Nov 2026, 11:26 pm
Vital Chemtech Reports Strong H1 FY27 Results and Board Reshuffle Vital Chemtech approved unaudited results for the quarter and half-year ended 30th Sep'26. Consolidated H1 FY27 revenue from operations grew 56.7% YoY to ₹10,117.54 lakh, while consolidated net profit surged nearly fourfold to ₹517.34 lakh from ₹135.35 lakh in H1 FY26. For Q2 FY27, consolidated PAT stood at ₹254.46 lakh versus ₹37.59 lakh YoY. Additionally, the board appointed Mukeshkumar Kanazariya and Bhavik Pandit as Independent Directors for five years, while Independent Directors Ajay Kumar Agrawal and Deepakkumar Chaubisa resigned effective 3rd Nov'26.
Original exchange filing (PDF)
More announcements from Vital Chemtech Ltd
- Vital Chemtech Limited has informed the Exchange about Resignation of Director/KMP/SMP · 03 Nov 2026
- Vital Chemtech Limited has informed the Exchange about Resignation of Director/KMP/SMP · 03 Nov 2026
- Vital Chemtech Limited has informed the Exchange regarding Resignation of Mr. Ajay Kumar Agrawal as Non- Executive Independent Director of the company w.e.f. November 03, 2026. · 02 Nov 2026
- Vital Chemtech Limited has informed the Exchange regarding Appointment of Mr. Bhavik Shirish Pandit as Non- Executive Independent Director of the company w.e.f. November 03, 2026. · 02 Nov 2026
- Vital Chemtech Limited has informed the Exchange regarding Appointment of Mr. Mukeshkumar Kanazariya as Non- Executive Independent Director of the company w.e.f. November 03, 2026. · 02 Nov 2026
- Vital Chemtech Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026 and Other agenda. · 02 Nov 2026
- Vital Chemtech Limited has informed the Exchange about Board Meeting to be held on 02-Nov-2026 to consider and approve the Quarterly Unaudited Financial results of the Company for the period ended September 2026 and Other business. · 02 Nov 2026
- Vital Chemtech Limited has informed the Exchange about Board Meeting to be held on 02-Nov-2026 to consider and approve the Quarterly Unaudited Financial results of the Company for the period ended September 2026 and Other business. · 02 Nov 2026
